Results for tag: "Hiatal Hernia Drug"

The Hiatal Hernia Drug market is a subset of the Gastrointestinal Drugs market. It is composed of drugs used to treat hiatal hernias, a condition in which the stomach protrudes through the diaphragm into the chest cavity. These drugs are used to reduce the symptoms of hiatal hernia, such as heartburn, chest pain, and difficulty swallowing. Commonly prescribed drugs include proton pump inhibitors, H2 blockers, and antacids. Surgery is also an option for more severe cases. The Hiatal Hernia Drug market is highly competitive, with many large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, GlaxoSmithKline, AstraZeneca, Merck, and Novartis. Other companies, such as Allergan, Boehringer Ingelheim, and Sanofi, also offer products in this market. Show Less Read more